ARQT logo

Arcutis Biotherapeutics (ARQT) EBIT

annual EBIT:

-$112.22M+$117.09M(+51.06%)
December 31, 2024

Summary

  • As of today (May 24, 2025), ARQT annual earnings before interest & taxes is -$112.22 million, with the most recent change of +$117.09 million (+51.06%) on December 31, 2024.
  • During the last 3 years, ARQT annual EBIT has risen by +$94.13 million (+45.62%).
  • ARQT annual EBIT is now -2633.17% below its all-time high of -$4.11 million, reached on December 31, 2017.

Performance

ARQT EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

quarterly EBIT:

-$21.80M-$16.89M(-343.61%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARQT quarterly earnings before interest & taxes is -$21.80 million, with the most recent change of -$16.89 million (-343.61%) on March 31, 2025.
  • Over the past year, ARQT quarterly EBIT has increased by +$5.78 million (+20.96%).
  • ARQT quarterly EBIT is now -343.61% below its all-time high of -$4.91 million, reached on December 31, 2024.

Performance

ARQT quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

TTM EBIT:

-$106.44M+$5.78M(+5.15%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARQT TTM earnings before interest & taxes is -$106.44 million, with the most recent change of +$5.78 million (+5.15%) on March 31, 2025.
  • Over the past year, ARQT TTM EBIT has increased by +$77.45 million (+42.12%).
  • ARQT TTM EBIT is now -1688.09% below its all-time high of -$5.95 million, reached on December 31, 2018.

Performance

ARQT TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ARQT EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+51.1%+21.0%+42.1%
3 y3 years+45.6%+65.1%+54.3%
5 y5 years-160.2%+23.9%-64.2%

ARQT EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+62.1%-343.6%+78.8%at high+65.3%
5 y5-year-160.2%+62.1%-343.6%+78.8%-64.2%+65.3%
alltimeall time-2633.2%+62.1%-343.6%+78.8%-1688.1%+65.3%

ARQT EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$21.80M(+343.6%)
-$106.44M(-5.1%)
Dec 2024
-$112.22M(-51.1%)
-$4.91M(-85.9%)
-$112.22M(-32.3%)
Sep 2024
-
-$34.88M(-22.2%)
-$165.81M(+0.4%)
Jun 2024
-
-$44.85M(+62.6%)
-$165.11M(-10.2%)
Mar 2024
-
-$27.58M(-52.9%)
-$183.90M(-19.8%)
Dec 2023
-$229.31M(-22.5%)
-$58.50M(+71.1%)
-$229.38M(-2.8%)
Sep 2023
-
-$34.18M(-46.3%)
-$235.99M(-22.5%)
Jun 2023
-
-$63.64M(-12.9%)
-$304.61M(-0.6%)
Mar 2023
-
-$73.06M(+12.2%)
-$306.38M(+3.6%)
Dec 2022
-$295.81M(+43.3%)
-$65.10M(-36.7%)
-$295.81M(-2.1%)
Sep 2022
-
-$102.81M(+57.2%)
-$302.03M(+17.9%)
Jun 2022
-
-$65.41M(+4.7%)
-$256.20M(+10.1%)
Mar 2022
-
-$62.49M(-12.4%)
-$232.80M(+12.8%)
DateAnnualQuarterlyTTM
Dec 2021
-$206.36M(+52.1%)
-$71.33M(+25.2%)
-$206.36M(+22.7%)
Sep 2021
-
-$56.98M(+35.6%)
-$168.13M(+12.5%)
Jun 2021
-
-$42.01M(+16.6%)
-$149.45M(+4.5%)
Mar 2021
-
-$36.04M(+8.9%)
-$143.07M(+5.4%)
Dec 2020
-$135.68M(+214.6%)
-$33.10M(-13.6%)
-$135.68M(+17.4%)
Sep 2020
-
-$38.30M(+7.5%)
-$115.58M(+25.7%)
Jun 2020
-
-$35.63M(+24.3%)
-$91.92M(+41.8%)
Mar 2020
-
-$28.65M(+120.5%)
-$64.83M(+50.3%)
Dec 2019
-$43.13M(+118.6%)
-$12.99M(-11.3%)
-$43.13M(+19.5%)
Sep 2019
-
-$14.65M(+71.6%)
-$36.09M(+68.3%)
Jun 2019
-
-$8.54M(+22.8%)
-$21.44M(+66.2%)
Mar 2019
-
-$6.95M(+16.8%)
-$12.90M(+116.8%)
Dec 2018
-$19.73M(+380.6%)
-$5.95M
-$5.95M
Dec 2017
-$4.11M
-
-

FAQ

  • What is Arcutis Biotherapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics annual EBIT year-on-year change?
  • What is Arcutis Biotherapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics quarterly EBIT year-on-year change?
  • What is Arcutis Biotherapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics TTM EBIT year-on-year change?

What is Arcutis Biotherapeutics annual earnings before interest & taxes?

The current annual EBIT of ARQT is -$112.22M

What is the all time high annual EBIT for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high annual earnings before interest & taxes is -$4.11M

What is Arcutis Biotherapeutics annual EBIT year-on-year change?

Over the past year, ARQT annual earnings before interest & taxes has changed by +$117.09M (+51.06%)

What is Arcutis Biotherapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of ARQT is -$21.80M

What is the all time high quarterly EBIT for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high quarterly earnings before interest & taxes is -$4.91M

What is Arcutis Biotherapeutics quarterly EBIT year-on-year change?

Over the past year, ARQT quarterly earnings before interest & taxes has changed by +$5.78M (+20.96%)

What is Arcutis Biotherapeutics TTM earnings before interest & taxes?

The current TTM EBIT of ARQT is -$106.44M

What is the all time high TTM EBIT for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high TTM earnings before interest & taxes is -$5.95M

What is Arcutis Biotherapeutics TTM EBIT year-on-year change?

Over the past year, ARQT TTM earnings before interest & taxes has changed by +$77.45M (+42.12%)
On this page